Joincare Pharmaceutical Group Industry Co.,Ltd. Environmental Analytics
Environmental and financial analysis dashboard for Joincare Pharmaceutical Group Industry Co.,Ltd.. Industry: MANUFACTURING
Company Overview for Joincare Pharmaceutical Group Industry Co.,Ltd.
Highlights
Showing data for FY2022
Operational Environmental Cost
$231m
Operational Environmental Cost Intensity
9.38%
Total Environmental Cost
N/A
Total Environmental Cost Intensity
N/A
ΔOperational Environmental Cost (2020-2022)
$26m
Decoupling Rate (2020-2022)
2.78%
Adjusted EBITDA
$406m
Adjusted EBITDA Margin
16%
Environmental cost statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| OPERATIONAL SOCIAL COST OF CARBON | ||||
| 507.20% | 9.45% | -14.97% | ||
| 0.33% | 1.65% | 1.83% | 1.64% | |
| -16.91% | 12.95% | 10.29% | ||
| 9.60% | 6.61% | 7.55% | 8.75% | |
| $205m | $206m | $231m | $244m | |
| 0.44% | 12.25% | 5.36% | ||
| 9.93% | 8.26% | 9.38% | 10.39% | |
| INDIRECT SOCIAL COST OF CARBON | ||||
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. Scope 2: Social Cost of Carbon is calculated using market-based emissions data. | ||||
Environmental cost bridge
Showing data for FY2022
Integrated financial analysis
Highlights
Showing data for FY2022
Adjusted EBITDA Margin
16%
Adjusted EBIT Margin
12%
EV / Adjusted EBITDA
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
EV / Adjusted EBIT
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
Integrated income statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| INCOME STATEMENT | ||||
$2,068m | $2,495m | $2,466m | $2,347m | |
| 20.69% | -1.18% | -4.82% | ||
$1,527m | $1,921m | $1,828m | $1,689m | |
| 73.87% | 76.97% | 74.14% | 71.97% | |
$540m | $575m | $638m | $658m | |
| 26.13% | 23.03% | 25.86% | 28.03% | |
$457m | $477m | $517m | $509m | |
| 22.08% | 19.13% | 20.97% | 21.70% | |
| ENVIRONMENTAL COST DATA | ||||
$205m | $206m | $231m | $244m | |
| 9.93% | 8.26% | 9.38% | 10.39% | |
| FINANCIAL DATA ADJUSTED FOR OPERATIONAL ENVIRONMENTAL COST | ||||
$335m | $369m | $406m | $414m | |
| 16.20% | 14.77% | 16.48% | 17.65% | |
$251m | $271m | $286m | $266m | |
| 12.16% | 10.87% | 11.59% | 11.31% | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. | ||||
Environmental EBITDA bridge
Showing data for FY2022
Industry benchmark
MANUFACTURE OF PHARMACEUTICAL PREPARATIONS
Scope 1 (% of Sales)
1.83%
Scope 2 (% of Sales)
7.55%
Operational Environmental Cost Intensity
9.38%
Scope 3 (% of Sales)
N/A
Total Environmental Cost Intensity
N/A
Selected peer group
Showing data for FY2022
NAME | COUNTRY | OPERATIONAL ENV. COST | OPERATIONAL ENV. COST INTENSITY |
|---|---|---|---|
Joincare Pharmaceutical Group Industry Co.,Ltd. | N/A | $231m | 9.38% |
Loading similar companies data...
Industry distribution
Showing data for FY2022
Note: Outliers are calculated using the 1.5 * IQR method, where values outside Q1 - 1.5 * IQR and Q3 + 1.5 * IQR are considered outliers.
Estimated Social Cost of Carbon Scope 3 breakdown
Percentage breakdown of Social Cost of Carbon Scope 3 into various categories
Showing data for FY2022
SCOPE 3 CATEGORY | Company (USD) | Company % | Industry Avg (USD) | Industry Avg % |
|---|---|---|---|---|
Purchased goods (1 & 2) | N/A | N/A | N/A | N/A |
Energy-related activities (3) | N/A | N/A | N/A | N/A |
Upstream transportation (4) | N/A | N/A | N/A | N/A |
Waste (5) | N/A | N/A | N/A | N/A |
Business travel (6) | N/A | N/A | N/A | N/A |
Commuting (7) | N/A | N/A | N/A | N/A |
Upstream leased assets (8) | N/A | N/A | N/A | N/A |
Downstream transportation (9) | N/A | N/A | N/A | N/A |
Processing of products (10) | N/A | N/A | N/A | N/A |
Use of products (11) | N/A | N/A | N/A | N/A |
Final treatment of products (12) | N/A | N/A | N/A | N/A |
Downstream leased assets (13) | N/A | N/A | N/A | N/A |
Franchises (14) | N/A | N/A | N/A | N/A |
Investments (15) | N/A | N/A | N/A | N/A |
Total | $0m | 100.00% | $0m | 100.00% |
Scope 3 breakdown visualization
Showing data for FY2022